After a slow start, Africa has shifted up a gear in Covid-19 vaccine procurement, securing hundreds of millions of jabs from pooling initiatives amid efforts to gain ground in the global inoculation race.
So far only a small handful of African countries have started immunising their populations against Covid-19, starting with the Seychelles and more recently Mauritius.
Wealthier nations have been accused of bulk-buying excess doses directly from manufacturers -- limiting supply and securing better deals than governments with less purchasing clout.
Most African countries are relying on the African Union (AU) and the World Health Organization (WHO) to shoulder at least part of their inoculation campaigns by providing vaccines and helping to finance their rollout.
On Thursday, the AU announced it had secured 400 million doses of Covid-19 jabs for its members in addition to 270 million doses trailed earlier this month.
The WHO-backed Covax sharing facility is meanwhile said to be on track to deliver 600 million vaccines to the continent by the end of 2021.
Algeria reached a deal this month to buy Russia's contentious Sputnik-V vaccine, while Senegal is in talks to acquire doses of China's Sinopharm vaccine.
South Africa, the continent's worst virus-hit country, is expecting a first batch of 1.5 million Oxford-AstraZeneca vaccines on February 1.
Africa's most industrialised economy will also get nine million shots from Johnson & Johnson, if its vaccine is approved, and is negotiating with other undisclosed manufacturers.
Morocco's King Mohammed VI received a vaccine against Covid-19 on Thursday, the palace said.
It added that Morocco's countrywide free-to-all vaccination campaign will "roll out progressively and in tranches, reaching all Moroccan citizens and residents aged 17 and over" -- some 25 million people.
The virus has ravaged the densely populated cities of Casablanca and Sale, near Rabat.
During the virtual 2021 World Economic Forum this week, South Africa's President Cyril Ramaphosa lashed "vaccine nationalism," accusing rich countries of hoarding doses to the detriment of poorer counterparts.
It is estimated that Africa will need 1.5 billion vaccines to immunise 60 percent of its 1.3 billion inhabitants -- a potential threshold for herd immunity against Covid.
But the WHO on Thursday cautioned that Covax and the AU combined would only be able to deliver jabs for around one third of the continent this year.
"Reaching 30-35 percent (of the African population) could be a realistic assumption by the end of 2021," WHO Africa's immunisation coordinator Richard Mihigo said during a virtual press briefing.
Africa was likely to receive its first Covax vaccines before mid-February, he added, without specifying which countries would come first.
"By March we will definitely see most of the countries start vaccinating," Mihigo predicted.
"It is a slow start, but we are expecting that in the coming months things are going to ramp up."
While the AU says it has secured 670 million doses, delivery is expected to be slower, with only 50 million vaccines promised for between April and June so far.
The bulk of these pooled provisions will be Oxford-AstraZeneca vaccines, followed by a few million Pfizer-BioNTech jabs.
Time is ticking. Several African countries are struggling to contain a second virus wave that has proved more virulent than the first, piling pressure on weary staff and under-equipped hospitals.
To date the continent has recorded close to 3.5 million Covid-19 cases and 88,000 deaths, according to a tally compiled by AFP.
Those figures remain relatively low compared to other regions, but the threat is worsening.
On Thursday, the WHO warned that more than 175,000 new cases and 6,200 deaths had been reported over the last week alone, mostly in northern and southern Africa.
Recorded infections have increased by 50 percent in the last four weeks, and the number of deaths has doubled.
Even more concerning is a Covid-19 variant first identified in South Africa and now "powering record case numbers" across Africa, the WHO said.
Known as 501Y.V2, it is thought to be more contagious and has cropped up in at least six African countries and 24 worldwide.
"What's keeping me awake at night right now is that it's very likely circulating in a number of African countries," said WHO Africa Director Matshidiso Moeti in a statement.
The WHO is supporting African countries to build and boost genomic surveillance capacities needed to track and respond to other potential variants.
Moeti called on governments to ramp up testing in the meantime and continue enforcing social distancing measures.
"In addition to the new variants, Covid-19 fatigue, and the aftermath of year-end gatherings risk powering a perfect storm," she urged.
